RIVN Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||
net income | -1,446,000,000 | -1,521,000,000 | -1,367,000,000 | -1,195,000,000 | -1,349,000,000 | -1,723,000,000 | -1,724,000,000 | -1,712,000,000 | -1,593,000,000 | -2,461,000,000 |
depreciation and amortization | 280,000,000 | 270,000,000 | 256,000,000 | 223,000,000 | 188,000,000 | 199,000,000 | 174,000,000 | 161,000,000 | 118,000,000 | 113,000,000 |
stock-based compensation expense | 233,000,000 | 215,000,000 | 242,000,000 | 181,000,000 | 183,000,000 | 293,000,000 | 242,000,000 | 317,000,000 | ||
inventory lcnrv write-downs and losses on firm purchase commitments | 150,000,000 | |||||||||
other non-cash activities | 53,000,000 | 69,000,000 | 39,000,000 | 5,000,000 | 2,000,000 | -5,000,000 | 24,000,000 | 16,000,000 | 47,000,000 | 12,000,000 |
changes in operating assets and liabilities: | ||||||||||
accounts receivable | -228,000,000 | 76,000,000 | 104,000,000 | -184,000,000 | -55,000,000 | 6,000,000 | -45,000,000 | -41,000,000 | 4,000,000 | |
inventory | -435,000,000 | -133,000,000 | -281,000,000 | -409,000,000 | -781,000,000 | -454,000,000 | -583,000,000 | -253,000,000 | -367,000,000 | -212,000,000 |
other assets | -81,000,000 | |||||||||
accounts payable and accrued liabilities | 113,000,000 | -115,000,000 | 204,000,000 | -6,000,000 | 22,000,000 | 144,000,000 | 58,000,000 | 220,000,000 | 201,000,000 | |
other liabilities | 92,000,000 | |||||||||
net cash from operating activities | -1,269,000,000 | -1,107,000,000 | -877,000,000 | -1,361,000,000 | -1,521,000,000 | -1,446,000,000 | -1,368,000,000 | -1,204,000,000 | -1,034,000,000 | -1,086,000,000 |
cash flows from investing activities: | ||||||||||
purchases of short-term investments | -902,000,000 | |||||||||
maturities of short-term investments | 550,000,000 | 700,000,000 | ||||||||
capital expenditures | -254,000,000 | -298,000,000 | -190,000,000 | -255,000,000 | -283,000,000 | -294,000,000 | -298,000,000 | -359,000,000 | -418,000,000 | |
net cash from investing activities | -606,000,000 | -603,000,000 | -432,000,000 | -1,193,000,000 | -283,000,000 | -294,000,000 | -298,000,000 | -359,000,000 | -418,000,000 | -456,000,000 |
cash flows from financing activities: | ||||||||||
proceeds from issuance of capital stock | 2,000,000 | 3,000,000 | 1,000,000 | 4,000,000 | ||||||
proceeds from issuance of convertible notes | 1,710,000,000 | 0 | 0 | 1,485,000,000 | 0 | |||||
other financing activities | -4,000,000 | -3,000,000 | -10,000,000 | -2,000,000 | -3,000,000 | |||||
net cash from financing activities | -2,000,000 | 1,621,000,000 | -8,000,000 | 32,000,000 | 1,485,000,000 | 37,000,000 | 6,000,000 | 14,760,000,000 | ||
effect of exchange rate changes on cash and cash equivalents | -1,000,000 | 2,000,000 | -3,000,000 | |||||||
net change in cash | -1,878,000,000 | -84,000,000 | -1,319,000,000 | -2,520,000,000 | -319,000,000 | -1,701,000,000 | -1,663,000,000 | -1,508,000,000 | -1,452,000,000 | 13,218,000,000 |
cash, cash equivalents, and restricted cash—beginning of period | 7,857,000,000 | 0 | 0 | 0 | 12,099,000,000 | 0 | 0 | 0 | 18,423,000,000 | 0 |
cash, cash equivalents, and restricted cash—end of period | 5,979,000,000 | -84,000,000 | -1,319,000,000 | -2,520,000,000 | 11,780,000,000 | -1,701,000,000 | -1,663,000,000 | -1,508,000,000 | 16,971,000,000 | 13,218,000,000 |
supplemental disclosure of non-cash investing and financing activities: | ||||||||||
capital expenditures included in liabilities | 383,000,000 | -16,000,000 | 52,000,000 | 5,000,000 | 333,000,000 | -10,000,000 | 16,000,000 | -48,000,000 | 406,000,000 | -14,000,000 |
capital stock issued to settle bonuses | 179,000,000 | 0 | 0 | 0 | 137,000,000 | |||||
right-of-use assets obtained in exchange for operating lease liabilities | 52,000,000 | 39,000,000 | 16,000,000 | 11,000,000 | 20,000,000 | 30,000,000 | 54,000,000 | |||
other incomes | ||||||||||
loss on convertible notes | -17,000,000 | |||||||||
other current assets | 0 | -18,000,000 | -33,000,000 | -11,000,000 | -15,000,000 | -17,000,000 | 7,000,000 | 11,000,000 | ||
other non-current assets | -17,000,000 | -29,000,000 | -20,000,000 | -18,000,000 | -8,000,000 | 5,000,000 | -13,000,000 | -6,000,000 | -2,000,000 | |
other current liabilities | -21,000,000 | 41,000,000 | 38,000,000 | 15,000,000 | 7,000,000 | 45,000,000 | 19,000,000 | 33,000,000 | 38,000,000 | |
other non-current liabilities | 77,000,000 | 38,000,000 | 48,000,000 | 54,000,000 | 44,000,000 | 25,000,000 | 26,000,000 | 6,000,000 | ||
proceeds from share issuance upon initial public offering, net of underwriting discounts and commissions and offering costs | ||||||||||
proceeds from issuance of capital stock including employee stock purchase plan | 22,000,000 | 2,000,000 | 37,000,000 | 7,000,000 | ||||||
proceeds from issuance of long-term debt | ||||||||||
purchase of capped call options | ||||||||||
supplemental disclosure of cash flow information: | ||||||||||
cash paid for interest | 1,000,000 | |||||||||
conversion of convertible notes | ||||||||||
conversion of convertible preferred stock | ||||||||||
inventory lcnrv charge and losses on firm purchase commitments | ||||||||||
purchase of short-term investments | -467,000,000 | |||||||||
inventory write-downs and losses on firm purchase commitments | -9,000,000 | 229,000,000 | 224,000,000 | 395,000,000 | 113,000,000 | 188,000,000 | ||||
stock-based compensation | ||||||||||
proceeds from issuance of long-term debt, net of discount and debt issuance costs | ||||||||||
principal payments and other financing activities | 0 | -1,000,000 | -1,000,000 | -1,000,000 | ||||||
warrants issuance | ||||||||||
customer deposits | 11,000,000 | 7,000,000 | 26,000,000 | |||||||
write-down of inventory | 64,000,000 | |||||||||
amortization of debt discounts and issuance costs | ||||||||||
current assets | ||||||||||
payables and accrued liabilities | ||||||||||
non-current liabilities | ||||||||||
decrease in note receivable due from affiliate | ||||||||||
capital expenditures—property, plant, and equipment | ||||||||||
capital expenditures—intangible assets | ||||||||||
proceeds from sale of fixed assets | ||||||||||
debt issuance costs | ||||||||||
principal payments on long-term debt | ||||||||||
principal payments under finance lease obligations | ||||||||||
supplemental disclosures of cash flow information: | ||||||||||
supplemental disclosure of non-cash investing activities: | ||||||||||
issuance of warrants |